Background: Antiplatelet treatment with aspirin and/or clopidogrel reduces the incidence of atherothrombotic events but does not Larder Fridge abolish them altogether.In a multifactorial pathological process such as atherothrombosis no single preventive strategy can be completely successful, yet prescribing antiplatelet treatment without routinely measuring its efficacy raises concern.Results: Several studies using different methods have shown that a substantial part of the population is non-responsive or semi-responsive to oral antiplatelet treatment.
These people have a higher incidence of atherothrombotic events, such as myocardial infarction, ischemic stroke, worsening of limb ischemia or cardiovascular death.The main problem in assessing non-responsiveness to antiplatelet treatment is that laboratory methods in vitro can only roughly estimate the function of platelets in vivo.Currently, there is no Outdoor Pub Table w/FP consensus either on standardized testing of platelet function or on clinical decisions based on testing, but several clinical studies are addressing these issues.
Conclusions: Current clinical guidelines do not recommend routine platelet function testing in patients on antiplatelet medication, but these guidelines may be revised in the future based on results of ongoing clinical studies.